Approval · Notice of Compliance 428 · 2003
ATACAND: Notice of Compliance 428
Issued February 13, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 428
- Date
- February 13, 2003
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New strength
- Therapeutic class
- Angiotensin ii at1 receptor blocker
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATACAND | 02239090 | Marketed |
Medicinal ingredients
- CANDESARTAN CILEXETIL 4 MG per TAB